[HTML] mdpi.com

[HTML][HTML] Quantitative FDG PET assessment for oncology therapy

K Hirata, N Tamaki - Cancers, 2021 - mdpi.com
Simple Summary PET enables quantitative assessment of tumour biology in vivo.
Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect tumour metabolic activity …
被引用次数：32 相关文章

Quantitative FDG PET Assessment for Oncology Therapy

K Hirata, N Tamaki - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Positron emission tomography (PET) has unique characteristics for quantitative assessment
of tumour biology in vivo. Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect …

Quantitative FDG PET Assessment for Oncology Therapy.

K Hirata, N Tamaki, M Hatt, A Sundín… - …, 2021 - search.ebscohost.com
Simple Summary: PET enables quantitative assessment of tumour biology in vivo.
Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect tumour metabolic activity …

Quantitative FDG PET Assessment for Oncology Therapy

K Hirata, N Tamaki - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Positron emission tomography (PET) has unique characteristics for
quantitative assessment of tumour biology in vivo. Accumulation of F-18 fluorodeoxyglucose …
[HTML] nih.gov

[HTML][HTML] Quantitative FDG PET Assessment for Oncology Therapy

K Hirata, N Tamaki - Cancers, 2021 - ncbi.nlm.nih.gov
Positron emission tomography (PET) has unique characteristics for quantitative assessment
of tumour biology in vivo. Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect …

Quantitative FDG PET Assessment for Oncology Therapy.

K Hirata, N Tamaki - Cancers, 2021 - europepmc.org
Positron emission tomography (PET) has unique characteristics for quantitative assessment
of tumour biology in vivo. Accumulation of F-18 fluorodeoxyglucose (FDG) may reflect …